Targeting disseminated melanoma with radiolabelled methylene blue: Comparative bio-distribution studies in man and animals

Acta Oncologica

Volumn 35, Issue 3, 1996, Pages 331-341

  Link, Eva M ^a   Costa, Durval C ^b   Lui, Dominic ^b   Ell, Peter J ^b   Blower, Philip J ^c   Spittle, Margaret F ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTATINE 211; IODINE 123; IODINE 131; METHYLENE BLUE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG DISTRIBUTION; DRUG EXCRETION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RADIOIODINATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0029982311     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609101650     Document Type: Conference Paper

References (26)

1. Goard EL, Fletcher MC. Toxic chorioretinopathy following the use of NP-207. Trans Am Ophthalmol Soc 1956; 54: 129-39.
2. Arden GB, Friedman A, Kolb H. Anticipation of chloroquine retinopathy. Lancet 1962; 1: 1164.
3. Forrest FM, Forrest IS, Roizin L. Clinical, biochemical and post mortem studies on a patient treated with chlorpromazine. Rev Agress 1963; VII: 147-52.
4. DeEds F, Stockton AB, Thomas JO. Studies on phenothiazine. VIII. Antiseptic value of phenothiazine in urinary tract infections. J Pharmacol Exp Ther 1939; 65: 353-71.
5. Tsuji S. Fixation of methylene blue-treated nervous tissue for histological and ultrastructural studies. Naturwissenschaften 1979; 66: 584-9.
6. Lavelle MA. Parathyroid adenoma stained with methylene blue. J R Soc Med 1980; 73: 462-3.
7. Potts AM. The reaction of uveal pigment in vitro with policyclic compounds. Invest Ophthalmol 1964; 3: 405-16.
8. Forrest IS, Gutmann F, Keyzer H. In vitro interaction of chlorpromazine and melanin. Rev Agress 1966; VII: 147-52.
9. Foster R, Hanson P. Electron-donor-acceptor complex formation by compounds of biological interest. I. Optical absorption spectra of mixtures of phenothiazines and related compounds with electron acceptors. Biochim Biophys Acta 1966; 112: 482-9.
10. Foster R, Fyfe CA. Electron-donor-acceptor complex formation by compounds of biological interest. II. The association-constant of various 1,4-dinitrobenzene-phenothiazine drug complexes. Biochim Biophys Acta 1966; 112: 490-5.
11. Larsson B, Tjälve H. Studies on the mechanism of drug binding to melanin. Biochem Pharmacol 1979; 28: 1181-7.
12. Link EM, Rydzy M. Endoirradiation of neoplastic tissues by administered radioisotopes. In: Proceedings of the Third Meeting of the Polish Biophysics Society, Wroclaw, 1978: 62.
13. 211At-methylene blue for pigmented melanoma in an animal model system. Cancer Res 1989; 49: 4332-7.
14. Link EM, Lukiewicz S. A new radioactive drug selectively accumulating in melanoma cells. Eur J Nucl Med 1982; 7: 469-73.
15. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: Treatment of micrometastases. Cancer Res 1990; 50: 2963-7.
16. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: Treatment of cutaneous tumors and lymph node metastases. Cancer Res 1992; 52: 4385-90.
17. 211At-methylene blue in targeted radiotherapy of disseminated melanoma. Pigment Cell Res 1994; 7: 358-62.
18. Humm JL. Dosimetric aspects of radiolabelled antibodies for tumour therapy. J Nucl Med 1986; 27: 422-7.
19. Smith IE, Courtenay D, Mills J, Peckham MJ. In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res 1978; 38: 390-2
20. West CML, Sandhu RR, Stratford IJ. The radiation response of V79 and human tumour multicellular sheroids - cell survival and growth delay studies. Br J Cancer 1984; 50: 143-51.
21. 123I-labelled methylene blue and toluidine blue: potential new agent for parathyroid scintigraphy. Nucl Med Commun 1990; 11: 413-20.
22. Jarritt PH, Kouris K. Instrumentation for brain SPECT: Guidelines and qualifications. In: Costa DC. Morgan GF, Lassen NA, eds. New trends in nuclear neurology and psychiatry. John Libbey & Co. Ltd., 1993: 39-62.
23. Kassis AI, Harris CR, Adelstein SJ, Ruth TJ, Lambrecht R, Wolf AP. The in vitro radiobiology of Astatine-211 decay. Radiat Res 1986; 105: 27-36.
24. Reynolds JEF. ed. Martindale- The Extra Pharmacopoeia. 28th ed., London: The Pharmaceutical Press, 1982: 384-5.
25. Arieff AJ, Pyzik SW. Quadriplegia after intrathecal injection of methylene blue. JAMA 1960; 173: 794-6.
26. Evans JP, Keegan HR. Danger in the use of intrathecal methylene blue. JAMA 1960; 174: 856-9.